End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
30.2 CNY | -1.40% | -3.36% | +30.45% |
19/04 | Haisco Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
18/04 | Haisco Pharmaceutical Gets Nod to Trial HSK16149 Capsules | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+30.45% | 4.61B | |
+29.98% | 682B | |
+32.39% | 586B | |
-3.52% | 364B | |
+18.59% | 327B | |
+4.07% | 285B | |
+16.50% | 240B | |
+9.56% | 209B | |
-9.04% | 203B | |
+7.09% | 165B |
- Stock Market
- Equities
- 002653 Stock
- News Haisco Pharmaceutical Group Co., Ltd.
- Haisco Pharmaceutical Wins Nod to Start Phase II Clinical Trial of Liver Disease Drug